인쇄하기
취소

Hanmi Pharm’s innovative anticancer drug ‘Posiotinib’ published in international SCI journal

Published: 2018-04-25 16:40:37
Updated: 2018-04-25 16:40:37

A research result of Poziotinib, a targeted therapy for cancer developed by Hanmi Pharm, was registered in the online version of Nature Medicine, an international SCI(Science Citation Index) journal.

Spectrum Pharmaceuticals, a U.S. partner of Hanmi Pharm(CEO Sae-Chang Kwon & Jong-Soo Woo), announced this in a press release on the 23rd(local time), and mentioned possibilities to smoothly devel...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.